Author = Hajar Estiri
Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy

Volume 21, Issue 4, July 2019, Pages 433-443

10.22074/cellj.2020.6309

Ali Fallah; Hajar Estiri; Elizabeth Parrish; Mansoureh Soleimani; Sirous Zeinali


Stable Knockdown of Adenosine Kinase by Lentiviral Anti-ADK miR-shRNAs in Wharton’s Jelly Stem Cells

Volume 20, Issue 1, January 2018, Pages 1-9

10.22074/cellj.2018.4916

Hajar Estiri; Ali Fallah; Masoud Soleimani; Abbas Aliaghaei; Fariba Karimzadeh; Shahnaz Babaei Abraki; Mohammad Hossein Ghahremani


Multiple Sclerosis Gene Therapy Using Recombinant Viral Vectors: Overexpression of IL-4, IL-10 and Leukemia Inhibitory Factor in Wharton’s Jelly Stem Cells in The EAE Mice Model

Volume 19, Issue 3, August 2017, Pages 361-374

10.22074/cellj.2017.4497

Ahmad Hosseini; Hajar Estiri; Haleh Akhavan Niaki; Akram Alizadeh; Baharak Abdolhossein Zadeh; Sayyed Mohammad Hossein Ghaderian; Akbar Farjadfar; Ali Fallah


Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune Diseases

Volume 16, Issue 3, October 2014, Pages 255-262

Shohreh Hajizadeh-Sikaroodi; Ahmad Hosseini; Ali Fallah; Hajar Estiri; Zahra Noormohammadi; Mohammad Salehi; Sayyed Mohammad Hossein Ghaderian; Haleh Akhavan Niaki; Masoud Soleimani; Bahram Kazemi